BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1875465)

  • 21. CA 125 assay used in conjunction with CA 15-3 and TAG-72 assays for discrimination between malignant and non-malignant diseases of the ovary.
    Einhorn N; Knapp RC; Bast RC; Zurawski VR
    Acta Oncol; 1989; 28(5):655-7. PubMed ID: 2590540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saliva and serum CA 125 assays for detecting malignant ovarian tumors.
    Chen DX; Schwartz PE; Li FQ
    Obstet Gynecol; 1990 Apr; 75(4):701-4. PubMed ID: 2179784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a multimarker assay for differential diagnosis of benign and malignant pelvic masses.
    Chen X; Zhou H; Chen R; He J; Wang Y; Huang L; Sun L; Duan C; Luo X; Yan H
    Clin Chim Acta; 2015 Feb; 440():57-63. PubMed ID: 25447698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The value of preoperative diagnosis before second-look laparotomy in ovarian cancer].
    Meden H; Rath W; Ohlmeyer D
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):101-5. PubMed ID: 2180783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis of ovarian tumors by transvaginal Doppler ultrasound with color flow imaging].
    Kawai M; Maeda O; Iwata M; Oguchi H; Kojima M; Kikkawa F; Tomoda Y
    Rinsho Byori; 1992 Feb; 40(2):146-51. PubMed ID: 1583786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative measurement of cancer antigen 125 (CA 125) in the differential diagnosis of ovarian tumors.
    Mogensen O; Mogensen B; Jakobsen A; Sell A
    Acta Oncol; 1989; 28(4):471-3. PubMed ID: 2789822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Doppler with two-dimensional sonography and CA 125 for prediction of malignancy of pelvic masses.
    Schneider VL; Schneider A; Reed KL; Hatch KD
    Obstet Gynecol; 1993 Jun; 81(6):983-8. PubMed ID: 8497367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transvaginal sonographic characterization of ovarian disease: evaluation of a new scoring system to predict ovarian malignancy.
    Sassone AM; Timor-Tritsch IE; Artner A; Westhoff C; Warren WB
    Obstet Gynecol; 1991 Jul; 78(1):70-6. PubMed ID: 2047071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peritoneal tuberculosis, large ovarian thecoma, and an elevated serum CA 125 level mimicking ovarian cancer.
    Hoffman MS
    J Fla Med Assoc; 1989 Apr; 76(4):388-9. PubMed ID: 2551992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ovarian cysts. The respective role of clinical examination, echography, biological markers and cytology].
    Forest AM; Brémond A; Lévèque J; Viallet A
    J Gynecol Obstet Biol Reprod (Paris); 1990; 19(7):829-36. PubMed ID: 2277165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyst fluid CA 125 levels in ovarian epithelial neoplasms.
    Menczer J; Ben-Baruch G; Moran O; Lipitz S
    Obstet Gynecol; 1993 Jan; 81(1):25-8. PubMed ID: 8416456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CA 125 in preoperative evaluation of pelvic masses.
    Pyrgiotis E; Salamalekis E; Loghis C; Dima C; Zourlas PA
    Eur J Gynaecol Oncol; 1993; 14(4):279-82. PubMed ID: 8344320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnostic significance of preoperative determination of CA-125 serum levels in the differentiation of malignant and benign pelvic masses].
    Durdević S; Segedi D; Vejnović T; Radeka G
    Med Pregl; 1992; 45(7-8):262-5. PubMed ID: 1344453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography.
    Stein SM; Laifer-Narin S; Johnson MB; Roman LD; Muderspach LI; Tyszka JM; Ralls PW
    AJR Am J Roentgenol; 1995 Feb; 164(2):381-6. PubMed ID: 7839975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for early ovarian cancer.
    Taylor KJ; Schwartz PE
    Radiology; 1994 Jul; 192(1):1-10. PubMed ID: 8208918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of tissue polypeptide specific antigen (TPS) in the diagnosis of ovarian malignancy.
    Padungsutt P; Thirapagawong C; Senapad S; Suphanit I
    Anticancer Res; 2000; 20(2B):1291-5. PubMed ID: 10810437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodiagnosis of ovarian tumors.
    Jacobs I; Bast RC
    Immunol Ser; 1990; 53():323-38. PubMed ID: 2100566
    [No Abstract]   [Full Text] [Related]  

  • 38. Sonography of pelvic masses in children: diagnostic predictability.
    Wu A; Siegel MJ
    AJR Am J Roentgenol; 1987 Jun; 148(6):1199-202. PubMed ID: 3554936
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic management of the adnexal mass.
    Parker WH; Berek JS
    Obstet Gynecol Clin North Am; 1994 Mar; 21(1):79-92. PubMed ID: 8015768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between sonographic morphology and Doppler waveform for the diagnosis of ovarian malignancy.
    Bromley B; Goodman H; Benacerraf BR
    Obstet Gynecol; 1994 Mar; 83(3):434-7. PubMed ID: 8127538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.